Deciphexback home

Latest news

20
Patholytix Preclinical
September 16, 2024

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation

read more
Patholytix Preclinical
July 11, 2024

Diagnexia Receives Accreditation from the College of American Pathologists

Diagnexia has successfully met the rigorous standards set by the College of American Pathologists (CAP).

read more
Patholytix Preclinical
May 30, 2024

Patholytix 4.0, Becomes First Platform to Support Future-proof Study Archival of Regulated Digital Safety Studies

Deciphex, a pioneering leader in GLP-compliant digital pathology solutions, announces today that it is the first DICOM-native platform to fully facilitate the archival and reconstruction of regulated digital studies. Previously unavailable, this advancement strengthens digital pathology's use in GLP drug safety assessment.

read more
Patholytix Preclinical
April 30, 2024

Diagnexia Accelerates Growth with Strategic Expansion within Exeter Science Park

Diagnexia, the digital pathology diagnostics leader and a division of Deciphex, today unveiled its strategic relocation to a larger facility within Exeter Science Park.

read more
Patholytix Preclinical
April 23, 2024

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development

read more
Patholytix Preclinical
April 11, 2024

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices

read more
Patholytix Preclinical
March 27, 2024

Deciphex Announce Web Based Enhancements to Patholytix, Enabling Any Time, Anywhere Peer Review

With the release of Patholytix 4.0, Deciphex introduces a new workflow, enabling users to access the platform through the web.

read more
Patholytix Preclinical
February 21, 2024

Diagnexia Partners with Aga Khan University Hospital to Enhance Pathology Services and Foster AI Diagnostic Innovations

Diagnexia, a leader in pathology expertise, is thrilled to announce a significant collaborative agreement with Aga Khan University Hospital (AKUH), Nairobi.

read more
Patholytix Preclinical
February 20, 2024

Deciphex Enables First Digital GLP Peer Review Conducted by a Consultant for a Contract Research Provider

In 2023, a Toxicological Pathologist at Integrated Biologix GmbH, Sarah Taplin, became the first consultant pathologist to perform a regulated digital peer review for a study conducted at a drug development research provider.

read more
Patholytix Preclinical
January 4, 2024

Deciphex Welcomes Dr. Pierre Moulin as Chief Scientific Officer to Help Shape the Future of Pathology AI

Deciphex, an innovator in Pathology AI, announces the strategic appointment of Dr. Pierre Moulin as Chief Scientific Officer.

read more
Patholytix Preclinical
December 14, 2023

Deciphex Celebrates Double Triumph: Medtech Company of the Year and Digital Health Innovation of the Year 2023

Deciphex is delighted to announce its recognition at the Irish Medtech Awards 2023.

read more
Patholytix Preclinical
October 16, 2023

Deciphex Secures €10m Venture Debt Financing to Accelerate Digital Pathology and AI Services Expansion

Deciphex, a trailblazer in digital pathology solutions, is delighted to announce a successful €10m venture debt financing round.

read more
Patholytix Preclinical
September 14, 2023

Deciphex and Xybion Digital join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows

Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in unified cloud software solutions for regulated industries.

read more
Patholytix Preclinical
August 24, 2023

Deciphex Accepted into MHRA GLP Monitoring Programme and Imminent Attainment of GLP Certification at Exeter Site

Deciphex, a pioneering leader in digital pathology solutions, is pleased to announce the acceptance of, Diagnexia UK Limited, into the Medicines and Healthcare products Regulatory Agency (MHRA) GLP Monitoring Programme as a prospective member, and the expected achievement of Good Laboratory Practice (GLP) compliance statement for its cutting-edge facility located in Exeter.

read more
Patholytix Preclinical
June 22, 2023

Diagnexia Expands Pathology Services with State-of-the-Art Accessioning Facility in Toronto, Revolutionizing Digital Pathology and Enhancing Patient Care

The Toronto Diagnexia Accessioning Office is Now Open

read more
Patholytix Preclinical
April 19, 2023

Diagnexia Announces Exeter Accession Facility Expansion with 30 New Jobs

The company has seen a 450% increase in demand for services since December. The expansion is expected to create numerous employment opportunities in the Exeter region, further stimulating the local economy.

read more
Patholytix Preclinical
February 2, 2023

Deciphex Completes Validation Activities Enabling Veterinary Consultant Pathologists To Perform GLP Peer Review Digitally Using Patholytix

This major advance means that veterinary consultant pathologists can work entirely in the digital domain and maintain GLP-compliance throughout a peer review. 

read more
Patholytix Preclinical
January 25, 2023

Deciphex Secures €3.9m Funding to Boost Digital Pathology and AI Services

The company is seeing a ten fold increase in demand quarterly and this strategic investment will allow them to grow their capacity, increase headcount, further improve services and expand to new markets.

read more
Patholytix Preclinical
January 12, 2023

Faster Study Delivery With Patholytix Automated Image QC

By building Automated Image QC into Patholytix 3.0, Deciphex delivers dramatically faster turnarounds of studies.

read more
Patholytix Preclinical
December 15, 2022

Patholytix Introduces Digital Pathology Review And Scoring In A Single Platform For The First Time

With Patholytix 3.0, Deciphex overcomes one of the last barriers to full-scale adoption of digital pathology.

read more
Patholytix Preclinical
October 18, 2022

Diagnexia Appointed as Supplier on NHS Telepathology Procurement Framework

Diagnexia Announce their Appointment as a Supplier on The Countess of Chester Hospital National Framework Agreement for Teleradiology, Telepathology and Telemedicine Services.

read more
Patholytix Preclinical
September 13, 2022

Patholytix Validated for GLP Primary and Peer Review

Reduces Time and Cost of Safety Assessment Studies

read more
Patholytix Preclinical
September 7, 2022

Digital pathology leader, Deciphex, launches its Diagnostics as a service (DxaaS) in the United States

Diagnexia is the first fully digital, subspecialty led, remote diagnostic & consult service.

read more
Patholytix Preclinical
July 26, 2022

Webinar: Using Patholytix AI to Identify Signs of Drug Toxicity in Preclinical Safety Assessment Studies

Join us for our webinar on Wednesday, July 27th, on the topic “Using Patholytix AI to Identify Signs of Drug Toxicity in Preclinical Safety Assessment Studies”.

read more
Patholytix Preclinical
June 23, 2022

Deciphex Presents Poster at STP 2022 - “Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps”

This week we were thrilled to get the opportunity to present our poster on the topic “Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps”.

read more
Patholytix Preclinical
June 7, 2022

Deciphex Enables Digital Pathology Primary Review for GLP Studies

Deciphex have announced today that they are first in industry to offer clients Good Laboratory Practice (GLP) compliant digital primary review.

read more
Patholytix Preclinical
May 19, 2022

Irish Digital Pathology and AI Company, Deciphex, Raises $11.5M in Series B Funding Led by ACT Venture Capital

Investment will fuel Deciphex’s role in using AI to accelerate pathology diagnostics, improving productivity and patient outcomes.

read more
Patholytix Preclinical
May 17, 2022

Deciphex at SFPT Congress 2022

Deciphex is participating in the French Society of Toxicological Pathology (SFPT) Congress 2022 in Toulouse, from the 19th - 20th of May.

read more
Patholytix Preclinical
May 3, 2022

Deciphex Launch Fully Outsourced AI Services for Non-clinical Digital Pathology

Deciphex have announced today that it is now a full service provider in Pathology AI and Quantitative Pathology.

read more
Patholytix Preclinical
April 1, 2022

Deciphex Appoints Dr. Trevor McKee to Spearhead Quantitative Pathology and Artificial Intelligence Service Delivery in Research Pathology

Deciphex announce that it has appointed Dr. Trevor McKee as Director of Commercial AI Services for Research Pathology to spearhead this exciting initiative.

read more
Patholytix Preclinical
March 22, 2022

Deciphex at Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo

Deciphex is exhibiting at the Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo happening in San Diego, California, from the 27-31st of March.

read more
Patholytix Preclinical
March 16, 2022

Deciphex Announce the Release of New Service Which Enables Veterinary Consultant Pathologists to Easily Onboard Digital Studies From Their Partners via Patholytix Preclinical

Deciphex have introduced a new service to facilitate on-demand sharing of studies with any veterinary consultant pathologist on a pay-per-use basis with zero cost to the consultant.

read more
Patholytix Preclinical
March 15, 2022

Deciphex at Digital Pathology & AI Conference 2022

Our Director of Commercial AI Services for Research Pathology, Trevor Mc Kee will be speaking at the Digital Pathology & AI Conference 2022 happening virtually, from the 24-25th of March.

read more
Patholytix Preclinical
February 15, 2022

Diagnexia at IBMS UK 2022

Diagnexia is exhibiting at the Institute of Biomedical Science (IBMS) Congress 2022 in Birmingham, from the 14th - 17th of March.

read more
Patholytix Preclinical
January 27, 2022

Diagnexia at Arab Health 2022

Deciphex is exhibiting at Arab Health 2022 in Dubai, one of the world's leading healthcare and health technologies events.

read more
Patholytix Preclinical
December 1, 2021

Diagnexia Launch the UK’s First, Fully Digital, Subspeciality Led, Backlog Management and Consult Service

Diagnexia, a new generation of technology-enabled care provider, powered by Deciphex’s core technologies, announces that they have secured CQC (Care Quality Commission) certification.

read more
Patholytix Preclinical
27 September 2021

Deciphex Launches Diagnexia, a Novel Service for Clinical Diagnostics

Deciphex, a leading provider of digital pathology and AI-powered services for clinical and non-clinical pathology, today announced that it has launched it’s novel clinical diagnostics service Diagnexia.

read more
Patholytix Preclinical
7 September 2021

Experience Patholytix at the Cutting Edge Pathology Virtual Congress this Month

Deciphex are pleased to announce our Gold Sponsorship of the 4th ESVP, ECVP and ESTP Cutting Edge Pathology Congress taking place on the 15th-17th of September.

read more
Patholytix Preclinical
5 July 2021

Deciphex are delighted to announce the launch of Patholytix Preclinical 2.1

This latest release of our award winning digital pathology platform delivers significant workflow improvements for our users and provides even greater support for early stage research applications through the introduction of Quantitative Pathology.

read more
Patholytix Preclinical
6 May 2021

Deciphex Makes Key Appointments to Strengthen Team in Advance of Mid 2021 Clinical Market Entry

Deciphex, a leading provider of digital pathology and AI-powered services, announced that it has appointed Prof Runjan Chetty as Chief Medical Officer, Luke Benko as Vice President of Global Pathology Services and Chris Polley as Clinical Business Manager UK.

read more
Patholytix Preclinical
22 April 2021

Deciphex Led Consortium Secure €3m to Develop Novel Prognostic Tests to Avoid Overtreatment of Cancer Patients

Deciphex is pleased to announce its success, in collaboration with partners Oncomark and UCD, in securing a €3m Government of Ireland, Disruptive Technologies Innovation Fund award to pursue its ongoing research program in cancer prognostics.

read more
Patholytix Preclinical
28 January 2021

Deciphex Announces Membership of new EU IMI BIGPICTURE Project Consortium, Aiming to Build the World's Largest Image Collection for the Validation of AI Models in Clinical and Non Clinical Pathology

To take AI development in pathology to the next level, a European consortium combining leading European research centres, hospitals as well as major pharmaceutical industries, is going to develop a repository for the sharing of pathology data.

read more
Patholytix Preclinical
9 December 2020

Deciphex Delivers Industry-first Patholytix Digital Pathology Peer Review for GLP Studies in Partnership with Charles River Laboratories

Deciphex and Charles River Laboratories International, Inc. (NYSE: CRL) have jointly announced today that they are the first in the industry to offer clients Good Laboratory Practice (GLP) validated digital peer review, using Deciphex Patholytix Preclinical for toxicologic pathology.

read more
Patholytix Preclinical
12 October 2020

Deciphex launch Patholytix Preclinical 2.0 enabling GLP Digital Pathology Peer Review

At Deciphex our mission is to enable our users to facilitate digital peer review of non-clinical pathology studies. We are delighted to announce the upcoming launch of Patholytix Preclinical 2.0 which provides our clients with a pathway to a regulated GLP Peer Review in conjunction with their CRO partners.

read more
Patholytix Preclinical
10 September 2020

Cernostics and Deciphex Announce Strategic Collaboration to Develop AI-Based Histology Diagnostics and Prognostics for Barrett's Esophagus

By combining Deciphex’s unique digital pathology solutions with Cernostics tissue systems pathology approach, the partnership aims to generate novel predictive indicators using AI.

read more
Patholytix Preclinical
September 7, 2020

PODCAST: How Deciphex is Accelerating the Non-clinical Drug Development Phase - Interview with Aleksandra Zuraw

Our CEO Donal O’Shea featured on the Digital Pathology Space’s podcast hosted by Aleksandra Zuraw this week to discuss how Deciphex is accelerating the non-clinical drug development phase.

read more
Patholytix Preclinical
18 August 2020

Deciphex are delighted to announce the launch of Patholytix AI 1.5

To mark the recent launch of Patholytix AI 1.5, we describe how Patholyix AI fits in the technology landscape available to AI developers working on Pathology AI projects, and how the platform can benefit them in accelerating impactful data generation for their pathology stakeholders.

read more
Patholytix Preclinical
9 July 2020

Deciphex Close $6.2m Series A Fundraising to Accelerate Commercialisation and Research Programs

Deciphex an Irish based technology player, developing ergonomic digital pathology workflows and AI for histopathology, has announced the conclusion of a $6.2m Series A fundraising which will empower the company to accelerate its research and development in Artificial Intelligence and to further accelerate market entry in preclincial/toxicologic digital pathology.

read more
Patholytix Preclinical
3 June 2020

Patholytix Preclinical 1.4 with Work from Home Mode

We understand that many of our partners now face changing work practices and are more reliant now than ever on remote collaborative tools to manage their day to day operations. Our team remains as committed and as capable as ever to supporting you, and to help you protect business continuity.

read more
Patholytix Preclinical
28 May 2020

Deciphex open US office in Chicago, Implement high throughput scanning service for clients.

Deciphex are delighted to announce the opening of its first US Facility as part of our planned US expansion.

read more
Patholytix Preclinical
30 March 2020

Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development with Digital Pathology

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leading company in the provisioning of global preclinical digital pathology services...

read more
Patholytix Preclinical
5 November 2019

Deciphex receives ISO 27001 certification

Deciphex, the leading global player in the provision of global preclinical digital pathology services, announced today that it has achieved certification against ISO 27001:2013, the premier global standard for Information Security Management Systems.

read more
Patholytix Preclinical
20 May 2019

Deciphex Applauded by Frost & Sullivan for its Machine Learning-powered Patholytix Preclinical Digital Pathology Platform

The Patholytix preclinical solution aids improved process efficiency in preclinical toxicology by adopting a unique pattern recognition approach.

read more
Patholytix Preclinical
15 April 2019

Deciphex Finalise 2.3m Equity Fundraising to Accelerate Commercialisation and Research Programs.

Deciphex an Irish based technology player, applying AI in pathology, has announced the conclusion of a €2.3m equity funding and convertible debt conversion event which will empower the company to accelerate its research and development in Artificial Intelligence and ramp up market entry in preclincial/toxicologic digital pathology.  

read more
Patholytix Preclinical
10 December 2018

Deciphex Successful in Securing €5.7m Disruptive Technologies Innovation Fund Award

Deciphex in conjunction with a number of high profile academic and industry collaborators have secured a significant grant to pursue the use of AI in colorectal cancer diagnostics and treatment.

read more
Patholytix Preclinical
15 November 2018

Deciphex featured in Irish Times

Bringing pathology into digital era to speed up disease diagnosis. Startup Deciphex uses a mix of artificial intelligence and computer-aided diagnostics
- Irish Times Article - 15th November 2018

read more
Patholytix Preclinical
8 November 2018

Deciphex Release Patholytix Preclinical

Deciphex are pleased to announce the release of their first commercial digital pathology product. Patholytix Preclinical is the first built for purpose digital pathology solution for preclinical/toxicologic pathology in pharma and clinical research organisations.  

read more
European Innovation Council Pilot
2 August 2018

Deciphex and GI Partners of Illinois Enter Strategic Alliance to Develop World’s Largest GI Pathology Content Database for Deep Learning.

Deciphex and GI Partners of Illinois, LLC (a large merger of several gastroenterology practices in Illinois) have established a strategic alliance to co-develop the world’s largest database of annotated, gastrointestinal (GI), digital pathology content for deep learning purposes.

read more
European Innovation Council Pilot
24 May 2018

Deciphex Awarded €2m from EU Fast Track to Innovation Program to Accelerate Development of AI Driven Workflows for Preclinical Pathology.

Deciphex in conjunction with commercial partners, Janssen Pharmaceuticals and PDS, has been awarded €2m from the EU Horizon2020, Fast Track to Innovation program, to accelerate development of artificial-intelligence based workflows for preclinical pathology.

read more
27 November 2017

Deciphex has filed two provisional patent applications directed to the field of abnormality detection.

Deciphex has established priority filing dates in the US on two inventions we believe will be critical to the future of Deep Learning in Pathology.

read more
31 October 2017

Pathology AI company, Deciphex closes first funding round, signs two collaboration agreements.

Deciphex is delighted to announce the closing of its first financing with support from key players in the Irish diagnostics industry.

read more
16 October 2017

Deciphex Selected for the EU SME Instrument Phase 1 Grant.

Deciphex is delighted to announce its successful awarding of an SME Instrument Phase 1 grant from the EU

read more

Contact Details

Invent Buidling at DCU

Ireland

Deciphex
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin
D11 KXN4

Call: +353 1 582 7193

Email: Info@deciphex.com

Twitter: @deciphex

USA

Deciphex Inc.
500 E Diehl RoadSuite 130,
Naperville,
IL 60563

Call: +1 708 573 0674

Email: info@deciphex.com

USA Headquarters Building

UK

Diagnexia
Hedy Lamarr Building,
3 Babbage Way,
Exeter,
EX5 2FN

Call: +44 1 29730 2245

Email: Info@deciphex.com

UK

Oxford Accessioning Centre (UK)
Diagnexia UK Ltd,
Building B,
‍Langford Locks,
Kidlington,
OX5 1LH

Email Us

The details you submit will be used so that we can contact you in relation to your query either by email or your preferred method of contact. Read our privacy policy here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form
Copyright Deciphex 2021
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.